Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine in type 2 diabetic patients in secondary failure to
combined oral therapy whether, besides improvement in glycemic control, addition of
exenatide, a new drug introduced to treat diabetes before addition of insulin to current
therapy, over 6 months is associated with improvement in beta-cell function, insulin
sensitivity following 24-hours discontinuation of the drug.
Phase:
Phase 4
Details
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain